Trial

NCT03970200

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
Condition
Severe Clostridium Difficile Infection
Intervention
Penn Microbiome Therapy - 001
Why stopped
Administrative reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-30